Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:N03AF01
|
| gptkbp:brand |
gptkb:carbamazepine
|
| gptkbp:chemicalClass |
dibenzazepine derivative
|
| gptkbp:contraindication |
history of bone marrow depression
hypersensitivity to carbamazepine |
| gptkbp:form |
extended-release capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Equetro
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Validus Pharmaceuticals
|
| gptkbp:mechanismOfAction |
sodium channel blocker
|
| gptkbp:pregnancyCategory |
D
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting dizziness drowsiness hyponatremia |
| gptkbp:usedFor |
bipolar disorder
seizure disorders |
| gptkbp:bfsParent |
gptkb:carbamazepine
|
| gptkbp:bfsLayer |
6
|